Anaphylaxis and angioedema are already described with other GLP-1 receptor agonists. Use warning within a affected person by using a history of anaphylaxis or angioedema with An additional GLP-1 receptor agonist as it is unfamiliar whether or not such sufferers are going to be predisposed to those reactions with Saxenda.Saxenda® is made up of lira